Simplifying Global Compliance
FDAnews Device Daily Bulletin
Johnson & Johnson Buys Synthes for $21.3 Billion to Boost Trauma Products
April 29, 2011
Johnson & Johnson agreed to buy Synthes for $21.3 billion in the biggest purchase of the company’s 125-year history, to become the leader in the $5.5 billion market for devices that treat trauma victims.
Copyright ©2017. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing